Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  1. Tolaney, S.M.
  2. Guarneri, V.
  3. Seo, J.H.
  4. Cruz, J.
  5. Abreu, M.H.
  6. Takahashi, M.
  7. Barrios, C.
  8. McIntyre, K.
  9. Wei, R.
  10. Munoz, M.
  11. Antonio, B.S.
  12. Liepa, A.M.
  13. Martin, M.
  14. Johnston, S.R.D.
  15. Kellokumpu-Lehtinen, P.-L.
  16. Harbeck, N.
Journal:
European Journal of Cancer

ISSN: 1879-0852 0959-8049

Year of publication: 2024

Volume: 199

Type: Article

DOI: 10.1016/J.EJCA.2024.113555 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals